|
|
|
|
|
| Why Biotechs Choose Australia for First-in-Human Trials | Embedded Video | By Trials Without Borders | Tina Soulis details Australia’s advantages for early-stage trials, including tax incentives, no IND requirement, and flexibility in trial design. She describes the typical biotech client profile and explains how adaptive trials are increasingly common. Tina also highlights that Australian-generated data is accepted by global regulators, strengthening biotech strategies. |
|
|
| Optimizing Global Early-Phase Oncology Trials | Article | By Keya Watkins and Marcia Milholen, Catalyst Oncology | By integrating strong partnerships, local expertise, and predictive analytics, sponsors and CROs can identify and activate the most suitable sites, accelerating trial delivery. |
|
|
| How Can Sponsors Enable Research-Naïve Clinical Trial Sites | Article | By Erik Moen, PA Consulting | Clinical trial capacity in the U.S. is heavily concentrated, and technology is playing a critical role in enabling a shift to expanding site networks and alleviating the burden on sites and patients. |
|
|
| From The Front Lines To First-In-Patient | Article | CSSi - An Elixia Company | Operating within local markets, LES professionals conduct meticulous eligibility assessments, manage referrals, and facilitate patient navigation, ensuring a seamless pre-screening experience. |
|
|
|
|
|
|
| Smart Sourcing: Patient Recruitment & Retention Showcase, a virtual event for clinical teams to explore and compare top patient recruitment and engagement partners. Expect live 15-minute demos, side-by-side comparisons, real-time Q&A, and practical insights to boost enrollment, diversity, and retention. Ideal for Clinical Ops, Site Engagement, and Vendor Management teams. Leave with a vetted shortlist of partners and actionable takeaways—without the time, cost, or travel of traditional conferences. |
|
|
|
| How Brazil's New Law Is Redefining The Country's Clinical Research | Guest Column | By Paulo Cesar Fernandes Jr. | Brazil aims to revamp its clinical research industry with the introduction of a new law intended to make trials faster, empower local ethics committees, and give patients greater post-trial access to investigational drugs. |
|
|
|
|
|
|
| Recruiter vs. Talent Acquisition Professional: What's the Difference? | Video | By Beyond The Protocol | In this clip, Katie Dunn clarifies the difference between a recruiter and a talent acquisition professional. She explains that a recruiter typically works for an agency, focuses on high-volume placements, and may have 30 or more positions to fill at a time. In contrast, a talent acquisition professional works in-house and acts as a consultant to hiring managers, guiding them through the hiring process. |
|
|
| The PXO Blueprint For Pediatric Clinical Trials | Article | Jumo Health | Address pediatric clinical trial challenges with a model that follows four foundational layers—Child Activation, Caregiver Confidence, Family System Enablement, and Site Adaptation. |
|
|
|
CHOOSE YOUR OWN ADVENTURE |
|
|
|
| You're receiving the Monday edition of the Clinical Leader newsletter, focusing on Clinical Sites, Patient Centricity, and Patient Recruitment. To make changes to your newsletter selections, update your topic preferences. - Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here. |
|
|
| Connect With Clinical Leader: |
|
|
|
